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Abstract 
Using a primer to a conserved nucleotide sequence of previously-cloned skin peptides of 
Phyllomedusa species, two distinct cDNAs were “shotgun” cloned from a skin secretion-
derived cDNA library of the frog, Phyllomedusa burmeisteri. The two ORFs separately 
encode chains A and B of an analog of the previously-reported heterodimeric peptide, 
distinctin. LC-MS/MS analysis of native versus dithiotreitol reduced crude venom, confirmed 
the predicted primary sequences as well as the cystine link between the two monomers. 
Distinctin predominantly exists in the venom as a heterodimer (A-B), neither of the 
constituent peptides were detected as monomer, whereas of the two possible homodimers (A-
A or B-B), only B-B was detected in comparatively low quantity. In vitro dimerization of 
synthetic replicates of the monomers demonstrated that besides heterodimer, both 
homodimers are also formed in considerable amounts. Distinctin is the first example of an 
amphibian skin dimeric peptide that is formed by covalent linkage of two chains that are the 
products of different mRNAs. How this phenomenon occurs in vivo, to exclude significant 
homodimer formation, is unclear at present but a “favored steric state” type of interaction 
between chains is most likely. 
 
Keywords: Amphibian skin peptides; cDNA cloning; distinctin; intramolecular disulfide 
bonds; peptidomics. 
 
1. Introduction 
 
Amphibians are known to release bioactive compounds from their skin granular glands that 
include alkaloids, steroids, biogenic amines, proteins and peptides [1, 2]. Many hundreds of 
different peptides, differing in size, charge, hydrophobicity, conformation, primary structure, 
as well as in post-translational modifications, have been demonstrated in frog defensive skin 
secretions. 
As already reported by Vittorio Erspamer, one of the original frog skin peptide researchers, 
frogs from the genus Phyllomedusa have skins that are “a treasure trove of biologically-active 
peptides” [3], due to the large quantities and structural diversity of the peptides that he found 
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in members of this taxon. Several Phyllomedusa skin peptides bear striking identities to 
mammalian (neuro)peptides [3, 4], and exhibit bioactivities in mammalian systems that are 
consistent with interaction with and activation of endogenous receptors. Other peptide classes 
include highly-potent antivirals and antimicrobials that are effective against bacteria as well 
as protozoa (recently reviewed [5, 6]). These rich sources of bioactive peptides are of 
particular interest to pharmacologists who are continuously searching for potential novel drug 
leads from unusual sources. Peptides thus far isolated from phyllomedusine skin, belong to 
diverse families, among which the dermaseptins and phylloseptins represent the largest both 
in terms of the numbers of peptide sequences identified and in the numbers of species in 
which they have been found [6]. The emergence of high throughput techniques such as 
tandem mass spectrometry based “peptidomics” and cDNA cloning have substantially 
assisted in enlarging the collection of sequences of bioactive (frog skin) peptides. 
Performance of high resolution mass spectrometry linked to efficient and robust (nano)HPLC 
or UPLC, is a very powerful combination strategy to collect (partial) amino acid sequence 
information straight from complex peptide mixtures. The data thus generated can then be 
validated and/or completed as soon as the nucleic acid sequences of the corresponding 
mRNAs become available. The latter has been facilitated by use of an efficient molecular 
cloning approach, developed by Chen and coworkers [7], based on the use of magnetic 
oligo(dT) beads to extract polyadenylated mRNA sequences directly from only a few 
milligrams of the actual frog skin secretion. This technique does not require dissected 
tissue(s) for mRNA extraction, and hence does not necessitate sacrificing secreting donor 
specimens. Indeed, harmless ‘gland milking’ appears sufficient to collect frog skin secretions 
rich in both peptides and (their) corresponding messenger RNAs. 
One successful strategy to “shotgun” clone novel skin peptide precursor-encoding cDNAs 
from frog skin cDNA libraries, has proven to be possible by the design of primers from 
highly-conserved nucleic acid sequences derived from skin peptide precursor-encoding 
cDNAs from related frog species [8, 9]. 
We here report the cloning and full structural characterization, directly from lyophilized P. 
burmeisteri skin secretion, of two peptide precursor-encoding cDNAs and their encoded 
peptides which are homologous to chains A and B from the heterodimeric peptide, distinctin, 
originally isolated from the skin of the related specie, P. distincta [10]. Differential analysis 
of native and reductively-alkylated P. burmeisteri distictin demonstrated that the 
intermolecular disulfide bridge between both chains is an endogenous and specific post-
translational modification (PTM). 
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Among the PTMs that are characteristic for amphibian skin peptides, disulfide bonds are not 
uncommon features. However, most of the cystines in frog peptides are intramolecular. The 
so-called Rana box, for example, is a conservative C-terminal motif of 5-8 residues between a 
cystine [11]. This is typical for certain classes of antimicrobial peptides that are active against 
Gram-positive/-negative bacteria and the yeast, Candida albicans, and is found in peptide 
groups including the brevinins, gaegurins, nigrocins, odoranains, esculentins, ranalexins, 
dybowskins, japonicins, palustrins and ranatuerins [12-16]. Other conserved internal 
disulfide-bridged domains in frog skin peptides are known, such as in the skin calcitonin-gene 
related peptide and the Kazal protease inhibitor peptides, found in P. bicolor and P. sauvagei, 
respectively [17, 18]. 
Intermolecular disulfide bonds, however, are quite rare in amphibian skin peptides. The only 
example so far is distinctin, a 5.4 kDa heterodimer composed of two different peptide chains 
containing 22 and 25 residues, respectively, that was originally identified in the skin secretion 
of the phyllomedusine frog, P. distincta. It has antimicrobial activity against Gram-negative 
and Gram-positive bacteria [10, 19, 20], and the dimerization was found to enhance the 
peptides’ bioactivity with respect to that of each monomer. In this context, heterodimeric 
peptides may represent a new class of amphibian skin peptide with potent 
biological/pharmacological activity that relies upon the formation of intermolecular 
complexes. This has inspired other researchers to actually engineer disulfide bridges into 
natural monomeric and linear amphibian skin peptides to form such complexes. Bioassays 
indeed subsequently confirmed that synthetic heterodimers, such as between magainin 2 and 
PGLa, and between magainin and its analogue pexiganan (i.e., MSI-78), showed a greatly 
enhanced antimicrobial activity when compared to the original native (monomeric) peptides 
[21]. 
 
2. Materials and Methods 
 
2.1.  Skin secretion collection 
About 10 specimens of Phyllomedusa burmeisteri, one of the Brazilian walking leaf frogs, 
were captured during expeditions (January 2009) in the Pacotuba Forest (Cachoeiro de 
Itapemirim City), and at a local farm (Brunoro’s, at Venda Nova do Imigrante City), both in 
the State of Espírito Santo (Brazil). Skin secretion samples were collected in the field by 
gentle transdermal electrical stimulation, essentially as described by Tyler and coworkers 
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[22]. The secretions were jet-washed from the sampled frog with deionized water, after which 
the donors were immediately released back into their natural environment. Skin secretions 
from several individuals (males and females) were filtered over cellulose acetate (0.2 µm pore 
size), pooled, frozen, lyophilized, and stored at -20 C prior to analysis. 
The required permit to access the genetic heritage information was obtained from the 
Brazilian Institute of Environment and Renewable Natural Resources (IBAMA license 
number 010453/2010-5). 
 
2.2.   Peptide separation and mass spectrometry 
One mg of lyophilized crude skin secretion was diluted in 25 mM NH4HCO3. This sample 
was divided in two. One part was reduced (2 mM dithiothreitol (DTT)) and alkylated (4 mM 
iodoacetamide (IAM)). Equivalents of 200 micrograms of both samples – native and reduced 
– were separately analyzed by HPLC (Waters 2695 Alliance, Manchester, UK), on a C4 
column (Reprosil C4, 5 μm particles, 2 mm x 150 mm, Dr. Maish, Germany) coupled on-line 
to a tandem mass spectrometer. The column was eluted (solvent A, 0.05% TFA, 0.1 M HAc; 
and B, 0.05% TFA, 0.1 M HAc in acetonitrile) by a linear gradient from 0 to 60% B at 0.75 % 
min
-1
, and the eluate was directly nanosprayed into a Q-TOF (QTof Premier, Waters, 
Manchester, UK). Of the crude secretion, 0.1 µg was also analyzed by nanoLC using a C8 
capillary column (Reprosil-Pur 120 C8, 5 μm particles, 150 mm, Dr. Maish, Germany) 
coupled to a linear trap-Orbitrap (Orbitrap Velos, ThermoFisher Scientific, Bremen, 
Germany).  
To facilitate the location of peptides containing cystine, PTM-driven differential peptide 
displays were generated by MSight (SIB, Geneva, Switzerland) as described earlier [23]. This 
proved an elegant way to assess the presence of the various distinctin dimers and monomers 
in both untreated and reduced secretions. 
For extensive targeted collision-induced fragmentation analysis of all distinctin ions, the 
respective peaks were manually selected at their retention times in a separate replicate LC 
MS/MS run. 
 
2.3.   Molecular cloning of distinctin peptides chains A and B 
Five mg of lyophilized skin secretion were dissolved in 1 ml of cell lysis/mRNA stabilization 
solution (Dynal, UK). Polyadenylated mRNA was isolated using magnetic oligo-dT beads as 
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described by the manufacturer (Dynal Biotech, UK). The isolated mRNA was subjected to 5’ 
and 3’- RACE procedures to obtain full-length peptide precursor nucleic acid sequence data 
using a SMART-RACE kit (Clontech UK). Briefly, the 3’-RACE reactions employed a nested 
universal primer (NUP - supplied with the kit) and a degenerate sense primer (N2-S1; 5’- 
ACTTTCYGAWTTRYAAGMCCAAABATG-3’), that was complementary to a conserved 
sequence 5’ to the putative signal peptide (including the startcodon ATG). This primer had 
been successfully used to clone different skin secretion peptides from other Phyllomedusa 
species [8, 9]. 3’-RACE reaction products were gel-purified, cloned using a pGEM-T vector 
system (Promega Corporation) and sequenced using an automated DNA sequencer (ABI 
3100). 
 
2.4.  Peptide synthesis and oxidation reactions 
A and B chains were synthesized by standard solid-phase Fmoc chemistry on an automated 
peptide synthesizer (Protein Technologies PS3, Tucson, AZ, USA).  
Molar equivalents of synthetic chains A and B were ‘incubated’ (one week at RT) with 
themselves or in combination in two different conditions: i) in H2O and ii) in 50 mM 
NH4HCO3 pH 8.0, containing 5% DMSO. In the H2O condition the synthetic chains were 
merely diluted in water individually and A plus B mixed, and analyzed by LC MS/MS. In the 
other condition the three possible combinations of chains (only A, only B and A plus B) were 
induced to oxidize in bicarbonate buffer in 5% DMSO pH 8.0, and measured by MS. 
 
3. Results 
 
3.1.  “Shotgun” cloning of distinctin chain precursor-encoding cDNAs 
To amplify the distinctin precursor-encoding mRNA sequences present in a cDNA library 
constructed from lyophilized P. burmeisteri skin secretion, a degenerate primer pool designed 
to a conserved nucleotide sequence upstream of the putative signal sequence of previously 
cloned Phyllomedusa skin peptides, was employed for its interrogation [8, 9]. Two full size 
preprodistinctin cDNAs were thus “shotgun” cloned yielding two different open reading 
frames (ORFs) with separate start and stop codons. 
The prepropeptide sequences can be predicted on the basis of putative prepropeptide 
convertase motifs and comparisons with similar peptides reported in the literature [7]. The 
open-reading frame (ORF) of the cDNA encoding the precursor of chain A, contains 69 
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amino acid residues, the first 22 of which, comprise a putative signal peptide, followed by a 
25-residue acidic ‘spacer’ peptide and finally the 22-residue mature distinctin A chain 
peptide. The ORF of the cDNA encoding the precursor of chain B contains 67 residues, that 
includes a 20-residue putative signal peptide, a 22- residue acidic spacer and a 25-residue 
mature distinctin B chain peptide (Fig. 1). 
The mature distinctin A- and B-chain peptide sequences are structurally very similar to those 
described for the original P. distincta peptide [10]. A significant difference in the primary 
structure is at residue 7 of the A-chain, which is an alanine (A) in the P. burmeisteri peptide, 
whereas the P. distincta homolog has a proline (P) in this position. 
 
3.2. Identification of homo- and heterodimers by MS 
MS analysis of crude P. burmeisteri skin secretion confirmed the existence of distinctin 
predominantly as a heterodimer (Fig. 2). The amino acid sequences of the chains were 
determined by collision-induced dissociation (CID) of both monomers that had been 
generated by reduction and alkylation of the venom components. MS/MS analysis was carried 
out using Q-TOF MS as well as by linear ion trap-Orbitrap tandem mass spectrometry. De 
novo sequencing of both chains, fully confirmed the sequences predicted from the “shotgun” 
cloned precursor cDNAs: a 22-residue mature A-chain: ENREVPAGFTALIKTLRKCKII, 
and a 25-residue mature B-chain, NLVSGLIEARKYLEQLHRKLKNCKV. In the DTT-
treated skin secretion, as expected, no dimers remained (neither homo- nor heterodimers), 
which can easily be seen in the PTM-driven differential peptide display of reduced versus 
untreated (native) sample (Fig. 3). 
The distinctin heterodimer, (A-B, m/z 779.45 (7+ charge state)), in the zoomed-in area of Fig. 
3) was present exclusively in the native sample (complete absence in the DTT-treated 
venom). On the other hand, the monomeric A-chain (m/z 625.96) and B-chain (m/z 738.92, 
four times charged), were entirely absent from crude native skin secretion indicating that in 
this, they are cross-linked (by cystine bonds) and that the native heterodimer was efficiently 
reduced by the DTT treatment. 
Likewise, targeted analysis identified the homodimer B-B in the native skin secretion (high 
resolution FTMS analyses; Fig. 2A). The ion intensity of the heterodimer is clearly higher 
than homodimer B-B, suggesting heterodimeric distinctin is present in a higher concentration 
than the homodimer B-B. No monomeric chain A or B, or any of the homodimer A-A, were 
detected in native skin secretion.  
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The heterodimer was observed at m/z 909.19 [M + 6H]
6+
, or parent mass 5,449.12 Da. This 
exactly equals the sum of the masses of chains A and B, minus the mass of 2 protons 
(disulfide formation from two cysteines). CID of this heterodimer ion precursor indeed 
yielded both b- and y-ions (as well as immonium ions) representing the N-terminal sequences 
of chains A and B (peaks highlighted in Fig. 2B). Sequence ions representing residues close 
to the cystine connection could not be identified, due to the covalent bond between the chains. 
Similarly the homodimer B-B, with an observed molecular mass of 5,901.34 Da was selected 
and CID fragmented, showing only chain B amino terminal sequence ions. The precursor 
mass as well as the occurrence of charge states higher than 8 (protonatable residues (R, K, H, 
and the amino terminus)) proved that it is indeed the covalent dimer. 
 
3.3. In vitro oxidation of synthetic replicates of distinctin A- and B – chains 
In an attempt to answer the intriguing questions as to how/why two peptide chains originating 
from two different ORFs preferentially form heterodimers, synthetic replicates of the peptide 
monomers were made and their in vitro dimerizations were studied by high resolution nano 
LC MS/MS. 
Synthetic A- and B-chains were either left to react in H2O or in bicarbonate buffer containing 
5% DMSO. In H2O, no dimer was formed (Fig. 4A-C). However, air oxidation of the chains 
in bicarbonate buffer containing 5% DMSO, induced partial dimerization. Chain A appeared 
nearly 100 % oxidized when left to react with itself (Fig. 4D), whereas the oxidation to form 
homodimer B-B, was incomplete (Fig. 4E). The oxidation reaction containing both chains, 
resulted in the formation of all possible dimers: heterodimer A-B, homodimer B-B and a little 
homodimer A-A. Only traces of chain A and B monomer remained (Fig. 4F). These oxidation 
reactions showed no clear preferential dimer formation. They also demonstrated that, in the 
absence of the other chain, both homodimers can be formed. 
To reiterate, the native frog skin secretion contained significantly more heterodimer A-B than 
homodimer B-B, whereas homodimer A-A was not detected. 
 
4. Discussion 
 
Here, we report the molecular cloning of cDNAs encoding the precursor sequences of two 
chains, A and B, that constitute the heterodimeric peptide, distinctin, from the skin secretion 
of Phyllomedusa burmeisteri. The corresponding mature peptide gene products were detected 
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in chromatographic fractions of the skin secretion as a distinctin heterodimer using MS. The 
only heterodimeric peptide described to date in amphibian skin secretions is the peptide, 
distinctin, from Phyllomedusa distincta, with a fully-established primary structure and 
antimicrobial activity [10]. The homodimer B-B, was also identified in the skin secretion of 
P. burmeisteri, and this is the first report of a naturally-occurring distinctin homodimer (Fig. 
2A). These data indicate that in vivo, distinctin has a strong tendency to exist as a disulfide-
bridged dimer. Heterodimerization seems to be preferred, but the detection of the homodimer 
suggests that rather than to exist as a monomer, excess peptide chains will homodimerize. 
Interestingly, the cloning and sequencing data indicate that the chains which in vivo are 
detected as heterodimers, are encoded by two different mRNA-encoded precursors, each with 
their own start and stop codon, that probably represent two distinct gene products. 
Scrutinizing the protein sequence database (UniProt) found that P. burmeisteri chain B 
exhibits a 71% sequence homology with a distinctin-like peptide chain sequence previously 
cloned from Phyllomedusa azurea [24]. This sequence does not contain any cysteinyl residues 
and a chain A equivalent in this species was not reported. Thus, this species of 
phyllomedusine frog provides further, albeit indirect evidence, that chain B appears not to be 
encoded by the same ORF as chain A. 
The mechanism behind the specific dimerization of the two P. burmeisteri chains from a pool 
of peptides containing single free cysteine residues, remains intriguing. Other natural hetero- 
and/or homodimeric peptides from venoms have been cloned and their nucleic acid sequences 
reported. These include the paralytic heterodimer, pimplin, from the wasp, Pimpla 
hypochondriaca [25]; the histamine-releasing homodimer, pilosulin 5, from the ant, 
Myrmecia pilosula [26]; hetero- and homo-dimeric D-conotoxins (VxXXA, VxXXB and 
VxXXC) found in the venoms of several marine cone snails of the genus Conus [27]; 
salmorin, a thrombin-induced fibrinogen-clotting inhibitor from the snake, Agkistrodon halys 
[28]; numerous dimeric disintegrins, cloned from Vipera and Echis snakes [29-31]; irditoxin, 
a neurotoxic dimer from the brown treesnake, Boiga irregularis [32]; and various secretory 
enzymes of the phospholipase A2 family, such as the heterodimers, imperatoxin I and 
phospholipidin from Pandinus imperator [33, 34] –, and HDP-1P and HDP-2P subunits of the 
neurotoxic and anti-coagulant heterodimer from Vipera nikolskii [35]. As in the case of the 
well-known example insulin [36], most of these heterodimers arise from a single mRNA 
precursor, which is translated in one continuous peptide sequence. This is thought to be a 
crucial step in the heterodimer formation, which occurs during or immediately after 
translation. A connecting peptide (of varying length in insulin and the various venom 
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heterodimers) between both mature chains is spliced out by specific endoproteases, and this 
occurs after the disulfide bridge(s) formation. 
The cDNAs of disintegrins, salmorin and irditoxin chains represent an exception to this rule, 
with both monomers encoded by different open reading frames. However, in all these cases, 
the pre-peptide sequences of A and B chains are very similar or almost identical (typically 
>70% sequence identity), which suggests that a gene duplication lies at the origin of both 
ORFs. In disintegrins, for example, it is suggested that the A chain precursor gene was 
derived from a B chain gene duplication. Subsequent deletion of a continuous and large base 
pair sequence of the ORF, encoding a C-terminal metalloprotease domain in the B chain pre-
peptide gene and of a N-terminal portion of the disintegrin domain, are thought to produce the 
final structure of the A chain [30]. Therefore, the disulfide connection between the subunits 
would proceed similarly as in homodimers (which are also detected in these venoms), where 
the dimerization takes place by virtue of the simultaneous presence of the chains in the 
endoplasmic reticulum (ER) during the translation process. 
The case of the heterodimeric P. burmeisteri distinctin is markedly different. The peptides 
representing the signal peptide, acidic spacer and mature peptide of each chain all exhibit 
different lengths as well as many sequence dissimilarities, yielding an overall sequence 
identity of only 47%. 
This suggests that a different mechanism may be behind the dimerization of these dissimilar 
subunit chains, perhaps comparable to what happens when antibody molecules 
(immunoglobulins) are maturing, with heavy and light chains translated from different 
chromosomes “finding” each other and oxidizing in the ER [37]. This is a hypothesis, and the 
actual mechanism of in vivo heterodimer formation is still unclear. 
In an attempt to obtain information on potential physicochemical constraints in the formation 
of the possible dimers from the two subunits identified, in vitro dimerization experiments 
were performed with synthetic replicates of the monomer peptides. However, this did not 
provide clues as to whether (sequence specific) physiochemical phenomena would preferably 
direct the formation of one dimer over the other. Our results indicate that both the heterodimer 
and the two homodimers can be formed in vitro. This is similar to what has been described for 
magainin and conotoxin synthetic dimers [38, 39]. It should be mentioned that during in-vitro 
oxidation experiments cystine formation could be induced by oxygen or trace amounts of 
metals. In addition, it is also very well possible that the synthetic peptides do not have the 
proper secondary/tertiary structure to promote chain specific dimerization and/or induce 
disulfide bond formation. 
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Although, in the native P. burmeisteri skin secretion the main compound detected was the 
heterodimer, followed by the homodimer B-B, no homodimer A-A, or A or B monomers, 
were detected. Why the heterodimer prevails in the P. burmeisteri skin secretion remains an 
unanswered question, and we can only speculate at this time. Structure modeling and NMR 
studies on the similar distinctin chains of P. distincta has indicated that matching hydrophobic 
areas on the outer surfaces of chain A and B and alpha-helices, may play a role in bringing 
both chains together [19, 40-42]. These studies, however, did not look at the structure of the 
homodimers. 
Comparative proteolytic degradation assays of distinctin and synthetic peptide analogues 
reported that distinctin is more resistant to serine protease breakdown as a heterodimer than as 
monomers or homodimers [19, 20]. The situation in the P. burmeisteri skin secretion, with 
most of the distinctin occurring as a heterodimer, may reflect a similar situation. 
Previous investigations have assessed the antimicrobial activity of all possible forms of the 
closely-related P. distincta distinctins [19, 20]. They found that the heterodimer has broad-
spectrum antimicrobial activity, and that the dimers (hetero- or homo-) are more active than 
the separate monomers. 
With the P. burmeisteri distinctins differing in only a single amino acid residue, the 
bioactivity is likely to be very similar. This would mean that the relative amounts of distinctin 
chains in the P. burmeisteri skin secretion is consistent with maximization of its bioactivity. 
To assess this, we performed pilot bioactivity studies (E. coli growth inhibition test) using 
dilution series of equivalent amounts of monomeric and in vitro dimerized synthetic peptides 
(see Fig. 4). Our preliminary data indicate that indeed the P. burmeisteri dimers have higher 
specific bioactivity than the monomers, and that the sample containing the heterodimer 
exhibits the highest antibiotic effect, confirming what was reported for P. distincta distinctin. 
With the present emergence of multiple-drug resistant strains of many pathogenic micro-
organisms and diseases requiring a pharmaceutical solution, the development of novel and 
potently-active pharmaceutical agents with potential clinical and therapeutic applications 
could be exemplified by natural molecules like the P. burmeisteri distinctin heterodimer 
reported here.  
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5. Conclusion 
 
Distinctin, a 5.4 kDa heterodimeric peptide with antimicrobial activity was identified within 
the skin secretion of Phyllomedusa burmeisteri. Molecular cloning of the cDNA encoding the 
two chains that constitute this heterodimeric peptide reveals they originate from two different 
mRNA-encoded precursors, each with their separate start and stop codon. MS analysis 
showed that in the crude venom the two chains are primarily present as the heterodimer A-B, 
a subfraction as homodimer B-B, whereas neither homodimer AA nor the individual A of B 
chains were observed. In vitro oxidation experiments with synthetic chains showed no 
preferential formation of hetero- of homodimer, suggesting there is an alternative mechanism 
for dimer formation in-vivo. To our knowledge this is the first example of an amphibian skin 
dimeric peptide that is formed by covalent linkage of two chains that are the products of 
different mRNAs. 
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Figures Legends 
 
Figure 1: Nucleotide sequences of precursor cDNAs encoding Phyllomedusa burmeisteri 
distinctin chain A (A) and distinctin chain B (B) cloned from a skin secretion-derived library. 
Putative signal peptides (double-underlined), mature processed peptides (single-underlined) 
and stop codons (asterisks) are indicated. 
 
Figure 2: Distinctin dimers in native P. burmeisteri skin secretion. (A) Combined MS 
spectrum of elution times in nanoLC chromatogram of both distinctin dimers. Spectrum 
shows presence of heterodimer (green peaks) and homodimer B-B (magenta peaks), among 
several other (higher and lower abundant) non-distinctin peptide peaks. Both distinctin dimers 
appear as multiply charged ions (z=5 until z=10) with heterodimer being most abundant. (B) 
Tandem MS of heterodimer (precursor ion at m/z 909.190 selected ([M+6H]
6+
)) showing b-, 
y-, and i- (immonium) ions from both chains A and B. Insert shows primary structure of chain 
A and B with all detected b- and y- ions indicated. 
 
Figure 3: Zoomed-in area of PTM-driven differential peptide display of native crude P. 
burmeisteri venom (in blue) and DTT-reduced venom (in red): inserts show [M+4H]
4+
 ions of 
distinctin monomeric chains A (A) and B (B) and [M+7H]
7+
 ions of distinctin heterodimer 
(AB). Note that sum of mass (A) and mass (B) minus mass (2H) exactly equals mass (AB). 
Ions common in both samples have blue and red colors superimposed, yielding blackish spots. 
Red color of monomers A and B indicate that these ions are not observed in native venom, 
whereas, conversely, blue heterodimer ions reveal that no heterodimer was detected in DTT-
reduced venom. (Full PTM-driven differential peptide display is provided as Supplementary 
Fig. 1). 
 
Figure 4: Deconvoluted MS spectra of in vitro dimerization of synthetic distinctin chains A 
and B. (A-C) “SYNTHETIC CHAIN(S) A/B/A&B” represent the mixture after one week of 
incubation of the respective chains in water. (D-F) “SYNTHETIC DIMERS A-A/B-B/A-B” 
show the oxidation products after one week in bicarbonate buffer pH 8.0. Masses of 
respective chains (monomers) and dimers are indicated by arrows. 
 
Supplementary Figure 1: Full PTM-driven differential peptide display of P. burmeisteri 
crude venom. Selected area is zoomed-in in Fig. 3. 
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Figure 1 
(A)  M  A  F  V   K  K  S   L  L  L   V  L  F  L   G  L  V · 
    1 ATGGCTTTCG TTAAAAAATC TCTTCTCCTT GTACTTTTCC TTGGATTGGT 
 TACCGAAAGC AATTTTTTAG AGAAGAGGAA CATGAAAAGG AACCTAACCA 
 · S  F  S   I  C  E  E   E  K  R   E  T  E   E  D  E  N · 
   51 CTCCTTTTCC ATCTGTGAAG AAGAGAAAAG AGAGACTGAA GAGGACGAGA 
 GAGGAAAAGG TAGACACTTC TTCTCTTTTC TCTCTGACTT CTCCTGCTCT 
 ·  E  D  E   I  E  E   E  S  E  E   K  K  R   E  N  R 
  101 ATGAGGATGA AATAGAGGAA GAAAGTGAAG AGAAGAAAAG AGAGAATCGA 
 TACTCCTACT TTATCTCCTT CTTTCACTTC TCTTCTTTTC TCTCTTAGCT 
  E  V  P  A   G  F  T   A  L  I   K  T  L  R   K  C  K · 
  151 GAAGTACCTG CAGGATTCAC TGCATTGATT AAAACATTAA GAAAGTGTAA 
 CTTCATGGAC GTCCTAAGTG ACGTAACTAA TTTTGTAATT CTTTCACATT 
 · I  I  * 
  201 GATTATATAA TCTAAGTAGT ACAGTTATCA ATGATTATGC CAAAACCATA 
 CTAATATATT AGATTCATCA TGTCAATAGT TACTAATACG GTTTTGGTAT 
  251 TTAAAGCATA TTTAATGTAA AAAAAAAAAA AAAAAAAAAA AAAAAAAA 
 AATTTCGTAT AAATTACATT TTTTTTTTTT TTTTTTTTTT TTTTTTTT 
 
(B)      M  A  F  L   K  K  S   L  F  L   V  L  F  L   V  F  L · 
    1 ATGGCTTTCC TTAAAAAATC TCTTTTCCTT GTACTATTCC TTGTATTCCT 
 TACCGAAAGG AATTTTTTAG AGAAAAGGAA CATGATAAGG AACATAAGGA 
 · S  L  C   E  E  E  K   R  E  E   E  N  E   E  K  Q  E · 
   51 TTCTCTCTGT GAAGAAGAGA AAAGAGAAGA GGAAAATGAG GAAAAACAAG 
 AAGAGAGACA CTTCTTCTCT TTTCTCTTCT CCTTTTACTC CTTTTTGTTC 
 ·  D  D  Q   S  E  E   K  R  N  L   V  S  G   L  I  E 
  101 AAGACGATCA AAGTGAAGAG AAGAGAAATC TGGTGTCAGG TCTAATAGAA 
 TTCTGCTAGT TTCACTTCTC TTCTCTTTAG ACCACAGTCC AGATTATCTT 
  A  R  K  Y   L  E  Q   L  H  R   K  L  K  N   C  K  V · 
  151 GCAAGAAAAT ACCTTGAACA GCTGCATCGT AAACTAAAAA ATTGTAAAGT 
 CGTTCTTTTA TGGAACTTGT CGACGTAGCA TTTGATTTTT TAACATTTCA 
 · * 
  201 TTAAGAAAAT GTAAAATCTA AGACCTCTAA GAGTGTTTTC ACACGGTGTG 
 AATTCTTTTA CATTTTAGAT TCTGGAGATT CTCACAAAAG TGTGCCACAC 
  251 TTTTTGGTGT GTTTTTTGAT GCATTTTTTG TGCAGAGAGG CACAGCAATT 
 AAAAACCACA CAAAAAACTA CGTAAAAAAC ACGTCTCTCC GTGTCGTTAA 
  301 AATGCTTGCA TTTCTGCACA GGGAAGGCGT CGGAAAACGC ACCAAAAGCA 
 TTACGAACGT AAAGACGTGT CCCTTCCGCA GCCTTTTGCG TGGTTTTCGT 
  351 CACCTTATGA AACCACCCTA AGGAGCACAA TTACCAATCA TTGTGCCAAA 
 GTGGAATACT TTGGTGGGAT TCCTCGTGTT AATGGTTAGT AACACGGTTT 
  401 ATAAAATCCA GCATATTTAA ACAAAAAAAA AAAAAAAAAA AAAAAAAAAA 
 TATTTTAGGT CGTATAAATT TGTTTTTTTT TTTTTTTTTT TTTTTTTTTT 
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Figure 4 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 21 
Graphical Abstract 
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Highlights 
 
1. Peptidome/transcriptome analysis of skin secretion of Phyllomedusa burmeisteri. 
 
2. The two chains of distinctin, a 5.4 kDa dimeric skin peptide, were shotgun cloned. 
 
3. Chains of this heterodimeric peptide are encoded by two different ORFs.  
 
4. In vivo, the hetero-dimeric distinctin is more abundant than homo-dimeric distinctin. 
 
5. In vitro oxidation of synthetic peptides showed no preferential hetero-dimerization. 
